The Clinicopathologic Significance of p53 and BAF250a (ARID1A) Expression in Clear Cell Carcinoma of the Endometrium

被引:0
|
作者
Fadare, O.
Gwin, K.
Desouki, M. M.
Crispens, M. A.
Jones, H. W., III
Khabele, D.
Mohammed, K.
Liang, S. X.
Zheng, W.
Hecht, J. L.
Parkash, V.
机构
[1] Vanderbilt Univ, Nashville, TN USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] UPMC, Pittsburgh, PA USA
[4] N Shore LIJ, Nhp, NY USA
[5] Univ Arizona, Tucson, AZ USA
[6] Harvard Univ, Boston, MA 02115 USA
[7] Yale Univ, New Haven, CT USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1138
引用
收藏
页码:273A / 273A
页数:1
相关论文
共 50 条
  • [21] LncRNA-GAS5 Inhibits Proliferation and Invasion of Ovarian Clear Cell Carcinoma via miR-221/ARID1A/BAF250a Axis
    Zhang, Jian
    Yang, Zhongmei
    Huang, Yu
    Wang, Kana
    Xie, Yao
    Yang, Nian
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 41 - 41
  • [22] Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
    Wiegand, Kimberly C.
    Lee, Anna F.
    Al-Agha, Osama M.
    Chow, Christine
    Kalloger, Steve E.
    Scott, David W.
    Steidl, Christian
    Wiseman, Sam M.
    Gascoyne, Randy D.
    Gilks, Blake
    Huntsman, David G.
    JOURNAL OF PATHOLOGY, 2011, 224 (03): : 328 - 333
  • [23] HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A
    Van Rechem, Capucine
    Boulay, Gaylor
    Leprince, Dominique
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 385 (04) : 586 - 590
  • [24] Clinicopathological Significance of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
    Maeda, D.
    Mao, T-L
    Fukayama, M.
    Wang, T-L
    Shih, I-M
    MODERN PATHOLOGY, 2011, 24 : 259A - 259A
  • [25] Significance of p53 expression in background endometrium in endometrial carcinoma
    Thuy Thi Nguyen
    Toru Hachisuga
    Rie Urabe
    Tomoko Kurita
    Seiji Kagami
    Toshinori Kawagoe
    Shohei Shimajiri
    Kazuki Nabeshima
    Virchows Archiv, 2015, 466 : 695 - 702
  • [26] Significance of p53 expression in background endometrium in endometrial carcinoma
    Thuy Thi Nguyen
    Hachisuga, Toru
    Urabe, Rie
    Kurita, Tomoko
    Kagami, Seiji
    Kawagoe, Toshinori
    Shimajiri, Shohei
    Nabeshima, Kazuki
    VIRCHOWS ARCHIV, 2015, 466 (06) : 695 - 702
  • [27] ARID1A MUTATION WITH LOSS OF PROTEIN EXPRESSION OF BAF250A MAY ACT AS AN EARLY EVENT IN THE TRANSFORMATION OF ENDOMETRIOSIS INTO OVARIAN CANCER
    Wu, C. H.
    Lin, H.
    Ou, Y. C.
    Haung, C. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1720 - 1720
  • [28] ARID1A MUTATION WITH LOSS OF PROTEIN EXPRESSION OF BAF250A MAY ACT AS AN EARLY EVENT IN THE TRANSFORMATION OF ENDOMETRIOSIS INTO OVARIAN CANCER
    Wu, C. H.
    Lin, H.
    Ou, Y. C.
    Haung, C. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 559 - 559
  • [29] ARID1A expression in ovarian clear cell carcinoma with an adenofibromatous component
    Nishikimi, Kyoko
    Kiyokawa, Takako
    Tate, Shinichi
    Iwamoto, Masami
    Shozu, Makio
    HISTOPATHOLOGY, 2015, 67 (06) : 866 - 871
  • [30] Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
    Maeda, Daichi
    Mao, Tsui-Lien
    Fukayama, Masashi
    Nakagawa, Shunsuke
    Yano, Tetsu
    Taketani, Yuji
    Shih, Ie-Ming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (12): : 5121 - 5129